ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,209Medicare Part D Prescriptions Filled, Including Refills

Rank: 403 out of 2094

$597K Total Retail Price of All Prescriptions

Rank: 350 out of 2094

416 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 416 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 416 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 6,491 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 390 359 1 2
SIMVASTATIN 332 315 2 1
ATORVASTATIN CALCIUM 251 239 3 5
LEVOTHYROXINE SODIUM 231 209 4 3
HYDROCHLOROTHIAZIDE 220 213 5 12
METOPROLOL SUCCINATE 189 169 6 9
DIOVAN 188 166 7 13
LOSARTAN POTASSIUM 178 168 8 17
OMEPRAZOLE 155 143 9 4
CITALOPRAM HBR 122 119 10 47
DIOVAN HCT 116 115 11 28
FUROSEMIDE 112 111 12 6
METOPROLOL TARTRATE 98 78 13 10
WARFARIN SODIUM 93 50 14 11
LISINOPRIL 87 81 15 7
AZITHROMYCIN 81 75 16 27
METFORMIN HCL ER 80 75 17 67
GLIMEPIRIDE 76 71 18 31
ALENDRONATE SODIUM 76 76 18 30
JANUVIA 73 61 20 35
LIPITOR 71 70 21 39
SYNTHROID 70 60 22 44
ZOLPIDEM TARTRATE 69 68 23 14
CRESTOR 64 57 24 15
FAMOTIDINE 64 44 24 34
FENTANYL 64 52 S2 24 68
DOXAZOSIN MESYLATE 62 46 27 120
BUPROPION XL 61 58 28 249
GLIPIZIDE 60 48 29 82
CARVEDILOL 59 59 30 19
PANTOPRAZOLE SODIUM 58 48 31 37
DONEPEZIL HCL 58 58 31 20
LOSARTAN-HYDROCHLOROTHIAZIDE 58 57 31 52
PAROXETINE HCL 56 43 34 77
BYSTOLIC 55 51 35 83
POTASSIUM CHLORIDE 53 52 36 24
NEXIUM 53 52 36 16
LANTUS 52 52 38 66
SERTRALINE HCL 52 52 38 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.